The expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children aged 2 to 18 with certain conditions, providing a ray of hope for parents.
Hyderabad-based Bharat Biotech, submitted data from phase 2/3 trials of Covid vaccine Covaxin for use in children aged 2 to 18 years to the Central Drugs Standard Control Organisation (CDSCO) earlier this month for verification and subsequent approval for emergency use authorisation (EUA) for the vaccine.
With the prospect of a children's vaccine on the horizon, parents are hoping that it will protect their children and be available soon.
Mukta Joshi, a 48-year-old teacher and mother of a 12-year-old son, stated that she has been very concerned about her son getting infected and is relieved to know of the development of the children's vaccine.
Mukta, who is eagerly awaiting the children's vaccine, stated that while all schools have now reopened, she is taking all precautionary measures to protect her son from any sort of gathering.
She said that the availability of children's vaccines is critical and should be made as soon as possible.
“It is extremely difficult to protect the child from infection as the virus is constantly mutating, and speculations about a third wave are a major source of concern,” said Mukta.
Himang, 12, said he misses going to birthday parties and seeing his friends because of Covid protocols and that he hopes to get the vaccine when it becomes available.
He said that his mother has restricted him and that many of his friends are also waiting for the vaccine.
Himang's elder sister, Vaishnavi, 18, said that while she received her vaccine dose, she believes that children over the age of 10 should receive it immediately.
"It's encouraging that the vaccine is nearing completion and will be available by the end of the year; we've been living in a fearful environment, and with children receiving vaccines soon, we'll be able to secure full family security and life will return to normal," she added.